Modified Opioid Peptides That Block Pain's Excitatory Side and Boost Relief
Modified dynorphin and beta-endorphin peptides selectively blocked excitatory opioid receptor functions, dramatically enhancing the pain-relieving effects of opioid drugs.
Quick Facts
What This Study Found
N- or C-terminus modified dynorphin and beta-endorphin selectively blocked excitatory opioid receptor functions, dramatically enhancing the pain-relieving effects of opioid agonists.
Key Numbers
How They Did This
Mouse dorsal root ganglion (DRG) sensory neurons in culture. Calcium-dependent action potential duration measured as an index of excitatory vs. inhibitory opioid effects. Modified peptides tested for selective blockade.
Why This Research Matters
If the excitatory opioid function can be selectively blocked, opioid pain relief could be greatly enhanced with lower doses, potentially reducing side effects and addiction risk.
The Bigger Picture
If the excitatory side of opioid receptors can be selectively blocked, patients might need far lower doses of opioid painkillers — potentially reducing addiction risk, side effects, and overdose deaths while maintaining or improving pain relief.
What This Study Doesn't Tell Us
In vitro study in cultured mouse sensory neurons. The bimodal opioid receptor concept is not universally accepted. Translation to whole-animal or human pain treatment is uncertain.
Questions This Raises
- ?Can this excitatory opioid blockade approach be translated into clinically usable drugs?
- ?Would chronic blockade of excitatory opioid functions prevent tolerance development?
Trust & Context
- Key Stat:
- Picomolar potency Modified opioid peptides blocked excitatory functions at extremely low concentrations, enhancing pain relief
- Evidence Grade:
- Moderate — controlled in vitro electrophysiology study with clear dose-response data, though the bimodal opioid receptor concept remains debated.
- Study Age:
- Published in 1995. The bimodal opioid receptor theory has generated both supporting evidence and controversy. Some modified peptides based on this concept have entered clinical development.
- Original Title:
- Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.
- Published In:
- Brain research, 673(1), 30-8 (1995)
- Authors:
- Shen, K F, Crain, S M
- Database ID:
- RPEP-00342
Evidence Hierarchy
Frequently Asked Questions
How can opioids both cause and relieve pain?
Opioid receptors appear to have two modes: at very low doses they can excite pain neurons (making pain worse), while at higher doses they inhibit them (relieving pain). This dual nature may contribute to opioid tolerance.
Could this lead to safer painkillers?
Potentially. If the excitatory opioid function is blocked first, much lower doses of opioids produce strong pain relief. Lower doses could mean less addiction risk and fewer side effects.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00342APA
Shen, K F; Crain, S M. (1995). Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.. Brain research, 673(1), 30-8.
MLA
Shen, K F, et al. "Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.." Brain research, 1995.
RethinkPeptides
RethinkPeptides Research Database. "Specific N- or C-terminus modified dynorphin and beta-endorp..." RPEP-00342. Retrieved from https://rethinkpeptides.com/research/shen-1995-specific-n-or-cterminus
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.